Active Not RecruitingNCT05849402

Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolarity type II

Device studyAges 18–80United States

The study in practice

Understand this study

Listed age limits: 18 years to 80 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: December 20, 2022

Recruitment status: Active Not Recruiting
Enrollment listed in the registry: 60
Sponsor: Stanford University
Sponsor type: University
Study type: Device
Intervention type: DEVICE
Study phase: Not clearly listed
Locations: United States
Age range: From 18 Years to 80 Years
Official registry ID: NCT05849402
Official title: Show the full official title
Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Not recruiting

Palo Alto

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Stanford University, a university.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.